HealthTree
Foundation
Donate
Log In
Discover more
Video
BETA - How is GPRC5D being targeted in myeloma?
Posted by
HealthTree
• June 9, 2026
Description
BETA - How is GPRC5D being targeted in myeloma?
On this video
Ajai Chari, MD
Related Content
News
Talquetamab (Talvey) Improves Survival for Relapsed/Refractory Multiple Myeloma Earlier in Treatment
News
Early Results of Investigational Bispecific Antibody for Relapsed/ Refractory Multiple Myeloma